From professional translators, enterprises, web pages and freely available translation repositories.
5d.
5.d
Last Update: 2017-04-06
Usage Frequency: 2
Quality:
item 5d))
5 d) punkts).
Last Update: 2017-04-06
Usage Frequency: 1
Quality:
article 5d
5.d pants
Last Update: 2017-04-06
Usage Frequency: 11
Quality:
annex 5d
5.d pielikums
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
article 5d 1.
1.
Last Update: 2014-10-23
Usage Frequency: 1
Quality:
annex v point 5d
v pielikuma 5.d punkts
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
annex 5d — cng compatibility test
5.d pielikums – sdg saderības tests
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
(5 = 5a + 5b + 5c + 5d)
= 5.a + 5.b + 5.c + 5.d)
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
articles 5(1), 5c and 5d
5. panta 1. punkts, 5.c pants un 5.d pants
Last Update: 2014-11-18
Usage Frequency: 1
Quality:
organising the risk assessment procedure in accordance with articles 5c and 5d;
organizē riska novērtēšanas procedūru saskaņā ar 5.c un 5.d pantu;
Last Update: 2017-04-06
Usage Frequency: 1
Quality:
the following paragraphs 5a, 5b, 5c, 5d and 5e are inserted:
pievieno šādu 5.a, 5.b, 5.c, 5.d un 5.e punktu:
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
in order to verify this compatibility, the procedure specified in annex 5d shall be used.
lai pārbaudītu šo saderību, izmanto 5.d pielikumā norādīto procedūru.
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
adverse reactions reported in ckd 5d and ckd nd patients are presented in tables 1 and 2, respectively.
nevēlamās blakusparādības, kas norādītas hns 5d un hns nd pacientiem, ir norādītas attiecīgi 1. tabulā un 2. tabulā.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
2 ml = 1 dose 5d 2 ml = 1 dose 10 d 2 ml = 1 dose 25 d
2 ml = 1 deva 5d 2 ml = 1 deva 10d 2 ml = 1 deva 25d
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
member states shall adapt the use of the gears mentioned in point 5d.1 in respect of the utilisation of its cod quota.
dalībvalstis pielāgo 5.d.1. punktā minēto rīku izmantošanu mencu kvotas izlietojumam.
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
secondary end-points included change of pain, global rating of quality of life by euroqol-5d, lung cancer symptom scale, and changes in karnosfky performance status.
sekundārie rezultāti ietver sāpju izmaiņas, kopējo dzīves kvalitātes vērtējumu pēc euroqol-5d, plaušu vēža simptomu skalas un karnosfky performance status pārmaiņas.